At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,025 enrolled
Drug / intervention
Prospective Chart Reviewother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
COVID-19 in Patients With Chronic Liver Diseases
In Brief
An observational study evaluating Prospective Chart Review for COVID-19 and Chronic Liver Disease. Completed, enrolled 1,025 participants across 23 sites.
Detailed Summary
This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19, Chronic Liver Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartMar 2020
First PostedJun 2020
Primary CompletionJul 2021
TodayJul 2026
First PostedJun 19, 2020
Enrollment StartMar 6, 2020
Primary CompletionJul 31, 2021
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 6.0 years ago
Interventions
Prospective Chart Reviewother
Collected data will include demographic features, clinical characteristics, clinical outcome, medication use, COVID-19-related complications in patients with chronic liver disease.